Shots: The BLA submission will be based on P-III EMERGE and ENGAGE studies that were discontinued in Mar’2019 following a futility analysis. The new analysis of larger dataset showed that […]readmore
Tags : Plan
Shots: The companies filed for their Nesp biosimilar in Oct’2018 with its awaited launch in H2’19 The original drug was developed in collaboration with US’ Amgen and Japan’s Kyowa Hakko […]readmore